Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis

JF Imberti, WY Ding, A Kotalczyk, J Zhang, G Boriani… - Heart, 2021 - heart.bmj.com
Objective To assess the efficacy and safety of catheter ablation (CA) compared with
antiarrhythmic drugs (AADs) as first-line treatment for symptomatic paroxysmal atrial …

Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: a meta-analysis of randomized clinical trials

MK Turagam, D Musikantow, W Whang… - JAMA …, 2021 - jamanetwork.com
Importance Early rhythm control of atrial fibrillation (AF) with either antiarrhythmic drugs
(AADs) or catheter ablation has been reported to improve cardiovascular outcomes …

Repeat catheter ablation for atrial fibrillation

MS Brahier, DJ Friedman, TD Bahnson, JP Piccini - Heart Rhythm, 2024 - Elsevier
Catheter ablation of atrial fibrillation (AF) is an established therapy that reduces AF burden,
improves quality of life, and reduces the risks of cardiovascular outcomes. Although there …

Outcomes after cryoballoon ablation of paroxysmal atrial fibrillation with the PolarX or the Arctic Front Advance Pro: a prospective multicentre experience

N Tanese, A Almorad, L Pannone, P Defaye… - Europace, 2023 - academic.oup.com
Aims The aim of this study was to compare procedural efficacy and safety, including 1-year
freedom from AF recurrence, between the novel cryoballoon system PolarX (Boston …

Comparison of procedural efficacy and biophysical parameters between two competing cryoballoon technologies for pulmonary vein isolation: insights from an initial …

SC Yap, A Anic, T Breskovic, A Haas… - Journal of …, 2021 - Wiley Online Library
Introduction Recently a novel cryoballoon system (POLARx, Boston Scientific) became
available for the treatment of atrial fibrillation. This cryoballoon is comparable with Arctic …

[HTML][HTML] Comparison of the acute outcome of two cryoballoon technologies for pulmonary vein isolation: An updated systematic review and meta-analysis

A Assaf, RE Bhagwandien, T Szili-Torok, SC Yap - IJC Heart & Vasculature, 2022 - Elsevier
Initial experience suggests that the POLARx cryoballoon system (Boston Scientific) has a
similar procedural efficacy and safety as Arctic Front Advance Pro (AFA-Pro, Medtronic). We …

Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation

E Schuijt, D Scherr, G Plank, U Schotten, J Heijman - Europace, 2025 - academic.oup.com
Abstract In 1924, the Dutch physiologist Willem Einthoven received the Nobel Prize in
Physiology or Medicine for his discovery of the mechanism of the electrocardiogram (ECG) …

Comparison of procedural efficacy, balloon nadir temperature, and incidence of phrenic nerve palsy between two cryoballoon technologies for pulmonary vein …

A Assaf, R Bhagwandien… - Journal of …, 2021 - Wiley Online Library
Abstract Introduction In May 2020, a novel cryoballoon system (POLARx; Boston Scientific)
became available for catheter ablation of atrial fibrillation (AF). The design of the cryoballoon …

Second-generation cryoballoon versus contact force radiofrequency ablation for atrial fibrillation: an updated meta-analysis of evidence from randomized controlled …

C Wu, X Li, Z Lv, Q Chen, Y Lou, W Mao, X Zhou - Scientific Reports, 2021 - nature.com
Catheter ablation has been recommended for patients with symptomatic atrial fibrillation
(AF), with pulmonary vein isolation being the cornerstone of the ablation procedure. Newly …

Cryoballoon ablation for the treatment of atrial fibrillation in patients with concomitant heart failure and either reduced or preserved left ventricular ejection fraction …

R Rordorf, F Scazzuso, KRJ Chun… - Journal of the …, 2021 - Am Heart Assoc
Background Heart failure (HF) and atrial fibrillation (AF) often coexist; yet, outcomes of
ablation in patients with AF and concomitant HF are limited. This analysis assessed …